“…Decisions relating to prescribing methylphenidate in ADHD, and when to suspend or cease medication, are influenced by a range of individuals involved in raising, providing care for and teaching children/adolescents with ADHD – as well as the patients themselves as they become able to actively participate in the decision‐making process. Participants in this study described many ways in which methylphenidate improved the behaviour of the child, echoing reports in a number of other studies (Brinkman et al., ; Bussing & Gary, ; Cormier, ; Hansen & Hansen, ); the need to increase dose to maintain improvements in the longer term was also discussed in this study, in line with the MTA study that reported a 41% increase in the average total daily dose with long‐term treatment (Molina et al., ). Previous studies, as well as the current investigation, highlight the reality that many children have, at one time or another, experienced reduced appetite and difficulties in sleeping as well as suffered from psychological side‐effects in response to methylphenidate (Hansen & Hansen, ).…”